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Abstract
We examined the in vitro effect of human growth hormone (hGH) on hormone placental production 
and the modulation by opioids of this function. Small placental fragments from 12 term placentas were 
incubated at 37 degrees C in a 95% air and 5% CO2 atmosphere for 4 h with various concentrations of 
hGH (1-1000 ng/ml) or naloxone (3-500 ng/ml). Both hGH and naloxone increased the concentrations 
of human chorionic gonadotropin (hCG) and progesterone in the media. The effect of the hGH was 
dose-dependent and statistically significant at 10 ng/ml, while naloxone was able to increase hCG and 
progesterone production only at the highest doses (250-500 ng/ml). The concomitant treatment with 
ineffective doses of naloxone and hGH was able to enhance hCG and progesterone secretion reaching 
levels similar to those obtained with the highest doses of hGH alone. High naloxone concentrations 
significantly decreased both hCG and progesterone secretion induced by high doses of hGH. This study 
confirms the relevance of growth hormone in sustaining placental endocrine activities and indicates an 
effect of opioids in modulating these functions.
